Surgical Management of Women With Ovarian Cancer

Seminars in Oncology

Volumn 34, Issue 3, 2007, Pages 226-233

  Cooper, Amy ^a   DePriest, Paul ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN DERIVATIVE; TAXANE DERIVATIVE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; EMBRYOLOGY; FROZEN SECTION; GERM CELL; HISTOLOGY; HUMAN; HYSTERECTOMY; OVARIECTOMY; OVARY CANCER; PHYSICAL EXAMINATION; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; SEROLOGY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TRANSVAGINAL ECHOGRAPHY;

CHEMOTHERAPY, ADJUVANT; DECISION MAKING; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PREOPERATIVE CARE;

EID: 34249883820     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2007.03.010     Document Type: Article

References (30)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Ries LAG, Harkins D, Krapcho M, et al: SEER Cancer Statistics Review, 1975-2003, Bethesda, MD, National Cancer Institute. http://seer.cancer.gov/csr/1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006
3. Edwards B.K., Brown M.L., Wingo P.A., et al. : Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97 (2005) 1407-1427
4. In: Kurman R. (Ed). Blaustein's Pathology of the Female Genital Tract (2002), Springer, New York, NY
5. Gershenson D.M. Update on malignant ovarian germ cell tumors. CA Cancer J Clin 71 suppl 4 (1993) 1581-1590
6. Whitworth M.K., Whitfield A., Holm S., et al. Doctor, does this mean I'm going to starve to death?. J Clin Oncol 22 (2004) 199-201
7. Jong P., Sturgeon J., and Jamieson C.G. Benefit of palliative surgery for bowel obstruction in advanced ovarian cancer. Can J Surg 38 (1995) 454-457
8. Bailey C.L., Ueland F.R., Land G.L., et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol 69 (1998) 3-7
9. Vine M.F., Calingaert B., Berchuck A., et al. Characterization of prediagnostic symptoms among primary epithelial ovarian cancer cases and controls. Gynecol Oncol 90 (2003) 75-82
10. Ueland F.R., DePriest P.D., Desimone C.P., et al. The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecol Oncol 99 (2005) 400-403
11. Togashi K. Ovarian cancer: The clinical role of US, CT, and MRI. Eur Radiol 13 suppl 4 (2003) L87-L104
12. Kurtz A.B., Tsimikas J.V., Tempany C.M., et al. Diagnosis and staging of ovarian cancer: comparative values of Doppler and conventional US, CT, and MR imaging correlated with surgery and histopathologic analysis-Report of the Radiology Diagnostic Oncology Group. Radiology 212 (1999) 19-27
13. DePriest P.D., Varner E., Powell J., et al. The efficacy of a sonographic morphology index in identifying ovarian cancer: A multi-institutional investigation. Gynecol Oncol 55 (1994) 174-178
14. Ueland F.R., DePriest P.D., Pavlik E.J., et al. Preoperative differentiation of malignant from benign ovarian tumors: The efficacy of morphology indexing and Doppler flow sonography. Gynecol Oncol 91 (2003) 46-50
15. Fishman D.A., Cohen L., Blank S., et al. The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gnecol 192 (2005) 1214-1221
16. Kurjak A., Kupesic S., Sparac V., et al. Preoperative evaluation of pelvic tumors by doppler and three-dimensional sonography. J Ultrasound Med 20 (2001) 829-840
17. Modesitt S.C., Pavlik E.J., Ueland F.R., et al. Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obstet Gynecol 102 (2003) 594-599
18. Zurawski V.R., Knapp R.C., Einhorn N., et al. An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinoma. Gynecol Oncol 30 (1988) 7-14
19. Tateo S., Mereu L., Salamano S., et al. Ovarian cancer and venous thromboembolic risk. Gynecol Oncol 99 (2005) 119-125
20. Akahira J.I., Yoshikawa H., Shimizu Y., et al. Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective study. Gynecol Oncol 81 (2001) 398-403
21. Abdul S., Tidy J.A., and Paterson M.E. Can we identify the patients who are likely to undergo bowel resection at the time of surgery for ovarian cancer?. J Obstet Gynaecol 26 (2006) 357-362
22. Tamussino K.F., Lim P.C., Webb M.J., et al. Gastrointestinal surgery in patients with ovarian cancer. Gynecol Oncol 80 (2001) 79-84
23. Fa-Si-Oen P., Roumen R., Buitenweg J., et al. Mechanical bowel preparation or not?. Outcome of a multicenter, randomized trial in elective open colon surgery. Dis Colon Rectum 48 (2005) 1509-1516
24. Schwartz P.E. Neoadjuvant chemotherapy for the management of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 16 (2002) 585-596
25. Beauchamp T., and Childress J. Principles of Biomedical Ethics. ed 4 (1994), Oxford, Oxford, NY
26. In: Greene F.L., Page D.L., and Fleming I.D. (Eds). AJCC Staging Manual (2002), Springer-Verlag, New York, NY
27. Piver M.S., and Baker T. The potential for optimal (≤2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective study. Gynecol Oncol 24 (1986) 1-8
28. Hoskins W., Bundy B., Thigpen J., et al. The influence of initial surgery on progression-free interval (PEI) and survival (S) in optimal (<1 cm) stage III epithelial ovarian cancer (EOC). Society of Gynecologic Oncologists. Gynecol Oncol 45 (1992) 76 (abstr)
29. Ansquer Y., Leblanc E., Clough K., et al. Neoadjuvant chemotherapy for unresectable ovarian carcinoma. CA Cancer J Clin 81 (2001) 2329-2334
30. Barakat R.R., Sabbatini P., Bhaskaran D., et al. Intraperitoneal chemotherapy for ovarian carcinoma: Results of long-term follow-up. J Clin Oncol 20 (2002) 694-698